Skip to main content
Premium Trial:

Request an Annual Quote

AACC Teams with NCI on Proteomics Outreach

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The American Association for Clinical Chemistry (AACC) plans to collaborate with the National Cancer Institute on educational outreach programs aimed at informing the clinical lab community about proteomics standards and new technological advances in the field, according to AACC.

Under a memorandum of understanding, AACC will help NCI's Clinical Proteomics Technologies for Cancer program in its efforts to connect lab workers with biologists and clinicians to speed development, optimization, and standards for using proteomics to detect cancer-relevant proteins/peptides in clinical specimens, AACC said.

AACC said that the memorandum provides a framework for pursuing collaborations and educational events covering clinical proteomics research and the need for standards, best practices, community reagents, and data policies.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.